19.06.2014
- Canada's Valeant Pharmaceuticals is taking its hostile $50.8 billion bid to acquire Botox manufacturer Allergan directly to shareholders. Backed by activist shareholder Bill Ackman...
29.05.2014
- As expected, Canadian drugmaker Valeant Pharmaceuticals International raised the cash component of its offer for Botox manufacturer Allergan on May 28. Its new offer values the US...
14.05.2014
- A day after U.S. drugmaker Allergan rejected its initial takeover approach, Canada's Valeant Pharmaceuticals International said it would "improve" the unsolicited $47 billion offer...
13.05.2014
- U.S. drugmaker Allergan has rejected the $47 billion takeover bid of Canada-based Valeant Pharmaceuticals International, saying the suitor's proposed cost cuts of at least $2.7...
24.04.2014
- Canada's Valeant Pharmaceuticals International and activist investor Bill Ackman have made an unsolicited $47 billion bid to buy Botox maker Allergan in a move to create one of the...
